KPMG

Selecting the Right European Location for Life Sciences Activities

Agile and resilient: This is how manufacturers in the life sciences industry could be described during the Covid-19 pandemic. As disruption took hold in many other industries’ supply chains, life ­sciences companies moved to rapidly develop new products and build new capacity. They are maintaining this momentum, with pharmaceutical and biotech businesses showing continued interest in expanding existing operations in Europe or starting operations from scratch.

UK Business “Hung out to Dry” on Brexit

AkzoNobel Launches Global Chemicals Start-up Challenge

Big Pharma Targets Aspiring Biotechs

Another Record Year for M&A in the Pharmaceutical Industry

KPMG Expects 2016 to become Another Record Year for M&A in the Pharmaceutical Industry

Innovative Medicine with Rising Productivity Targets

Substance-based Supply-Chain Planning under BEPS

“Less-Than-Truckload Networks”

The European market for less-than-truckload (LTL) services is characterized by rising competition and price pressure.

Is Big Data the Next Big Thing?

The Formula For Success

Elemica Appoints Schneck as CFO

M&A in Chemicals & Pharmaceuticals

Brazil is Still to Score

US Markets Drive Global Reallocation and Growth

China’s chemical industry

Chemicals in the Middle East

The Miracle of Shale Gas

India Catalyzed

Cross-Border Buys

Solvias Research Team Receives "Sandmeyer Award 2012"

Solvias Research Team Receives Sandmeyer Award 2012

Going Green, Big Business Hires Auditors For Proof

The U.S. Chemical Industry’s Position in the World

Foreign Companies Stepping Away From Iran

Be Prepared